Evidence map›Paper›PMID 27777621›Full record

ArticleBiotechnology for biofuels2016

Genome editing of

Shilpa Nagaraju, Naomi Kathleen Davies, David Jeffrey Fraser Walker, Michael Köpke, Séan Dennis Simpson

Abstract read
In one paragraph

Article in Biotechnology for biofuels, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exploring auxotrophy and engineering vitamin BApplied and environmental microbiology · 2024
    Article
  7. Review
  8. Article
  9. Recent progress in engineeringSynthetic and systems biotechnology · 2024
    Review
  10. Article
  11. Review
  12. CRISPR-Based Gene Editing inPharmaceuticals (Basel, Switzerland) · 2023
    Review
  13. Refined control of CRISPR-Cas9 gene editing inFrontiers in immunology · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in bioengineering and biotechnology · 2022
    Article
  20. Reprogramming Microbial COFrontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shilpa NagarajuLanzaTech Inc, 8045 Lamon Ave, Suite 400, Skokie, IL 60077 USA.ORCID 0000-0003-3114-6056
Naomi Kathleen DaviesFaculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
David Jeffrey Fraser WalkerUniversity of Massachusetts, Amherst, MA USA.
Michael KöpkeLanzaTech Inc, 8045 Lamon Ave, Suite 400, Skokie, IL 60077 USA.
Séan Dennis SimpsonLanzaTech Inc, 8045 Lamon Ave, Suite 400, Skokie, IL 60077 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImpactful greenhouse gas emissions abatement can now be achieved through gas fermentation using acetogenic microbes for the production of low-carbon fuels and chemicals. However, compared to traditional hosts like

resultsIn this study, we report scarless genome editing of an industrially used model acetogen,

conclusionsAddition of both an inducible promoter library and a scarless genome editing tool is an important expansion to the genetic tool box of industrial

Indexed as

AcetogenClostridium autoethanogenumCRISPR/Cas9Gas fermentationGenome editingInducible promoter

Identifiers

PMID27777621
PMCPMC5069954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.